Categories: H. Pylori, Peptic Ulcer

January 2009 Volume 5, Issue 1

Nimish Vakil, MD

Download PDF

Treatment of Helicobacter pylori infection is indicated in a number of medical conditions, including peptic ulcer disease and localized gastric lymphoma. Antimicrobial-based triple therapy is the standard treatment used in most countries throughout the world, but its success rate has declined in many countries to the point where alternative and salvage therapies such as levofloxacin and rifabutin have gained importance in clinical practice. Sequential therapy is a newly described regimen that has been shown to be superior to triple therapy in some studies. In this article, we discuss current treatment strategies for H. pylori infection.